Sanofi (NYSE: SNY) announced that it has filed preliminary consent solicitation materials with the U.S. Securities and Exchange Commission ("SEC") ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hot Corp. News Management Changes Management Comments Mergers and Acquisitions Trader Talk

Medivation (MDVN) Urges Holders to Reject Sanofi's Attempt to Replace BoardMay 25, 2016 8:49 AM Sanofi Files Consent Solicitation To Remove and Replace Medivation's BoardMay 25, 2016 7:10 AM Stocks with Implied Volatility MovementMay 25, 2016 6:50 AM Form PREC14A MEDIVATION, INC. Filed by: SanofiMay 25, 2016 6:40 AM French drugmaker Sanofi to step up push into ChinaMay 25, 2016 5:05 AM Exclusive: Sanofi to unveil challenge to Medivation's board - sourcesMay 25, 2016 12:31 AM Arm of I-SPY 2 TRIAL Investigating Medivation's Talazoparib for Treatment of Breast Cancer ActivatedMay 23, 2016 7:00 AM